VevaRx review
VevaRx prices its NAD+ three-month plan at $399 in the buy card, $447 in the paragraph below it, and $267 in the billing panel below that. One page, three figures.
- Pricing grade
- FPrice unclear
- Monthly price
- $167/mo
- compounded semaglutide, monthly rate in the product page prose
- Price comparison
- $447 three-month total in the prose; $267 in the billing panel
- the paragraph below the card, and the billing panel below that
- FDA warning letter
- None found
Pricing transparency · How we grade · How we verify prices
Three figures for one plan on one page, none of them marked as superseding the others. There is no reading of that page that tells a buyer what the charge will be.
- Month-to-month price published
- States published: AZ, CA, CO, CT, FL, GA, HI, ID, IL, IN, IA, KY, ME, MD, MA, MI, MN, MO, MT, NE, NV, NH, NJ, NY, NC, OH, OK, OR, PA, SC, TN, TX, VA, WA, WI, WY
The verdict
The product cards and their accompanying descriptions quote conflicting charges. Monthly plans are published, but the applicable treatment charge needs confirmation. A state list is available.
Quick facts
Key facts
- Semaglutide, monthly
- $189 in the card, $167 in the prose
- Sermorelin, three months
- $399 in the card, $367 in the prose
- Glutathione, three months
- $349 in the card, $267 in the prose
- NAD+, three months
- $399, $447 and $267 on one page
- Tirzepatide, three months
- $467 total, $149 a month as printed
- PT-141, monthly
- $247 a month
- States served
- 36 named in the FAQ; the terms say all 50
- Mailing address
- None, including in the refund clause that asks for one
Pros and cons
What we like
- The FAQ publishes a list of state names rather than a claim about a number.
- Every product page carries a plain statement that compounded drugs are not FDA-approved and are not reviewed before marketing.
- The three-month cards print the total and the page's own per-month equivalent side by side.
- A compounding pharmacy and a telehealth partner are both named, though only in the privacy policy.
What could be better
- Every three-month product page gives two or three different figures for the same plan.
- The semaglutide monthly rate is $189 in the card and $167 in the prose on the same page.
- The terms carry recurring follow-up prices that appear on no product page.
- A first-month offer is described as a discount from a lower figure to a higher one.
- The terms claim all 50 states while the FAQ lists 36.
- No mailing address exists anywhere, including in the refund clause that requires writing to one, and the governing law names no state.
What it is
Six compounded products on six product pages: semaglutide, tirzepatide, sermorelin, glutathione, NAD+ and PT-141. The footnote on each says compounded drugs are not FDA-approved and that the FDA does not review them before marketing, which is the right disclosure, plainly worded.
One compounding pharmacy and one telehealth partner are named, and only inside the privacy policy — never on a product page. No prescriber is named anywhere, on a model where the prescriber is the entire clinical relationship.
The FAQ publishes an actual list of state names. That is more than most of this range manages, and it is the strongest thing on the site.
Every price we found at VevaRx
| Plan | Advertised | Published price | The gap |
|---|---|---|---|
| Compounded semaglutide, monthlyThe buy card says $189 a month; the program details paragraph on the same page says $167. | $189 | $167 | |
| Compounded semaglutide, three monthsThe card's own per-month equivalent of a $399 total. The prose below it quotes $467. | not published | $133/month equivalent quoted for three months | not comparable |
| Compounded tirzepatide, three monthsThe page's own per-month equivalent of a $467 total, with a three-month minimum and billing every three months. | not published | $149/month equivalent quoted for three months | not comparable |
| Sermorelin, three monthsThe card shows $399 total and $133 a month. The paragraph beneath prices the same plan at $367 total. | $133/month equivalent quoted in the card | $367 three-month total in the prose | not comparable |
| Glutathione, three monthsThe card shows $349 total and $117 a month. The paragraph beneath prices the same plan at $267 total. | $117/month equivalent quoted in the card | $267 three-month total in the prose | not comparable |
| NAD+, three monthsThe card shows $399 total and $133 a month, the prose $447, and the billing panel beneath that $267. | $133/month equivalent quoted in the card | $447 three-month total in the prose; $267 in the billing panel | not comparable |
| PT-141, monthlyA monthly plan, with a three-month option at $663 total on the same page. | not published | $247 | not comparable |
What it actually costs at VevaRx
The buy cards read: semaglutide $189 a month or $399 for three, tirzepatide $467 for three, sermorelin $399, glutathione $349, NAD+ $399, PT-141 $247 a month. Each card prints the page's own per-month equivalent beside the total.
Then the paragraph beneath each card gives a different number. Sermorelin becomes $367. Glutathione becomes $267. NAD+ becomes $447 in the prose and $267 again in the billing panel under it. Semaglutide's monthly becomes $167.
None of these is a promotion expiring or a term you did not read. Each is one page disagreeing with itself about the figure a buyer is about to be charged, which puts it in a different category from the ordinary headline-versus-real gap.
The terms then name recurring follow-up prices of $299 and $399 that appear on no product page, and describe a first-month offer as a discount from $179 to $199 — which is not a discount.
Who it's wrong for
- Skip it until the prices agree. Six product pages each carry two or three figures for one plan, and a price you cannot read off the page is not a published price.
- Check the state list against the terms. The FAQ names 36 states; the terms say the products are available across all 50. Both cannot be right.
- Note the follow-up charges before you start. The terms carry recurring figures the product pages do not, which is the sort of thing only the legal pages disclose.
- If you want a peptide line whose prices agree with themselves, Trellis Vitality publishes a single plan table.
Is VevaRx legit?
VevaRx is operated by VevaRx LLC, according to its privacy notice, opening sentence — the only place the legal name appears.
No FDA warning letters found
Pharmacy, prescribers and safety checks
- Compounding pharmacyOne named, in the privacy policy only
- Telehealth partnerNamed in the same place, never on a product page
- Named prescriberNone across the ten pages read
- Compounded statusStated on every product page, plainly
- Mailing addressNone, including in the refund clause that requires one
- Governing lawThe state in which VevaRx operates, which is never named
Common questions
What does VevaRx charge for semaglutide?
The buy card says $189 a month or $399 for three months. The paragraph on the same page says $167 a month and $467 for three. Both are live and neither corrects the other.
How much does tirzepatide cost at VevaRx?
$149 a month, and only on a three-month plan with a three-month minimum. That is the company's own per-month equivalent of the total in the buy card — the card its semaglutide page disagrees with.
Why do the NAD+ prices differ?
We do not know. That one page prints $399 in the card, $447 in the paragraph beneath it and $267 in the billing panel below that, with nothing marking any of them as superseded.
Are there charges beyond the plan price?
The terms name a follow-up consultation at $299 that appears on no product page, and describe the first month at $199 as a reduction from a figure that is lower, not higher.
Which states does VevaRx serve?
The FAQ lists 36 states by name. The terms separately say the products are available across all 50 states, so the two documents disagree about the answer.
How do I request a refund?
The terms say a request must be made within 28 days and submitted in writing to an email address or a physical mailing address. That mailing address is not printed anywhere on the site.
Why we gave VevaRx a F
Read the full grading rationale
Every three-month product page on this site contradicts itself between the buy card and the paragraph directly beneath it, and the reader has no way to tell which figure is charged. Sermorelin is $399 total in the card and $367 in the prose. Glutathione is $349 and $267. NAD+ publishes three figures for one plan: $399 in the card, $447 in the prose and $267 in the billing panel below that. Semaglutide's monthly plan is $189 in the card and $167 in the prose, and the prose's three-month total of $467 belongs to the tirzepatide page. That is not a stale page or a promotion expiring; it is one page disagreeing with itself, on six products, on the figure a buyer is about to be charged. Two further problems compound it. The terms disclose recurring follow-up prices of $299 and $399 that appear on no product page, and advertise a discount that is a price increase — originally priced at $179, currently offered at $199 for the first month. And the terms still refer to transactions being conducted on a different company's domain. The state position is genuinely useful — the FAQ names 36 states — but the terms claim availability across all 50, which contradicts it. VevaRx LLC is named once, in the privacy policy; no mailing address appears anywhere, including in the refund clause that asks you to write to one; and the governing law is given as the state in which VevaRx operates, which is never named. One pharmacy and one telehealth partner are named, and only in the privacy policy. FDA warning letter: none found (checked October 2026). No address is published anywhere on the site.
Read the evidence
How we reviewed VevaRx
We read the company's own pages: six product pages, the FAQ, the terms, the privacy policy and the homepage.
Each contradiction we describe sits on a single page, quoted word for word.
Where each price comes from
- Semaglutide product page page
Monthly Treatment $189 /month Convenient Monthly Plan
- Tirzepatide product page page
3 Months Tirzepatide Complete Plan $467 total Equivalent to $149 per month
- Sermorelin product page page
3 Months of Sermorelin Care Complete Plan $399 total Equivalent to $133 per month
- Glutathione product page page
3 Months of Glutathione Care Complete Plan $349 total Equivalent to $117 per month
- Nad product page page
3 Months of NAD+ Care Complete Plan $399 total Equivalent to $133 per month
- Pt 141 product page page
PT-141 Treatment FLEXIBLE $247 /month Convenient Monthly Plan
- Vx terms and conditions page
Originally priced at $179, currently offered at $199 for the first month. This package includes the Telehealth consultation, prescription, GLP-1 medication, shipping, and ongoing medical support if needed.
Alternatives to VevaRx
| Provider | Grade | Published price context |
|---|---|---|
| Nova MD | BMinor gap | From $175/mo for compounded semaglutide, one month billed monthly |
| Blue Haven Rx | CCaveat | From $179/mo for compounded semaglutide |
| Yucca Health | BMinor gap | From $146/mo for compounded semaglutide |
| Brello Health | CCaveat | Published $133/mo equivalent for compounded semaglutide, three month plan — prepaid term, not monthly payments |
| TeleZen MD | CCaveat | From $168/mo for compounded semaglutide, billed monthly |